M. Sezik , O. Ozkaya , E. Arslanoglu , A. Koker , H. Cetin , D. Ozbasar , H. Kaya
{"title":"羊膜内表面活性剂对早产绵羊肺成熟的影响","authors":"M. Sezik , O. Ozkaya , E. Arslanoglu , A. Koker , H. Cetin , D. Ozbasar , H. Kaya","doi":"10.1016/j.jeas.2006.09.004","DOIUrl":null,"url":null,"abstract":"<div><p><span>We aimed to evaluate the effects of intra-amniotic surfactant administration on alveolar lecithin/sphingomyelin ratio, density of type II pneumocytes<span>, and fetal lung function in preterm merino<span> sheep. Pregnant ewes at 119 days gestation either received 200</span></span></span> <!-->mg intra-amniotic surfactant (<em>n</em>=4) or saline solution (<em>n</em>=4). After 24<!--> <!-->h, the lambs were delivered by hysterotomy and mechanically ventilated. Lecithin/sphingomyelin ratios in alveolar fluid, inflating pressure–volume relationships, and type II pneumocyte counts in histological specimens were compared among the groups. All of the lambs completed the protocol. Mean lecithin/sphingomyelin ratio increased significantly in amniotic (<em>p</em>=0.03) and alveolar fluid (<em>p</em>=0.03) samples of surfactant-treated animals. Lung function in terms of pressure–volume curves did not differ between two groups. Type II pneumocyte density tended to be higher (<em>p</em>=0.057) after intra-amniotic surfactant administration. Single-dose treatment with intra-amniotic surfactant seems to improve amniotic and alveolar lecithin/sphingomyelin ratio questionably by increasing alveolar type II cells. Pressure–volume relationships from inflation of the lungs might be unaltered with intra-amniotic surfactant treatment.</p></div>","PeriodicalId":77206,"journal":{"name":"Journal of experimental animal science","volume":"43 4","pages":"Pages 301-307"},"PeriodicalIF":0.0000,"publicationDate":"2007-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jeas.2006.09.004","citationCount":"5","resultStr":"{\"title\":\"Evaluation of intra-amniotic surfactant administration for lung maturation in preterm sheep\",\"authors\":\"M. Sezik , O. Ozkaya , E. Arslanoglu , A. Koker , H. Cetin , D. Ozbasar , H. Kaya\",\"doi\":\"10.1016/j.jeas.2006.09.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>We aimed to evaluate the effects of intra-amniotic surfactant administration on alveolar lecithin/sphingomyelin ratio, density of type II pneumocytes<span>, and fetal lung function in preterm merino<span> sheep. Pregnant ewes at 119 days gestation either received 200</span></span></span> <!-->mg intra-amniotic surfactant (<em>n</em>=4) or saline solution (<em>n</em>=4). After 24<!--> <!-->h, the lambs were delivered by hysterotomy and mechanically ventilated. Lecithin/sphingomyelin ratios in alveolar fluid, inflating pressure–volume relationships, and type II pneumocyte counts in histological specimens were compared among the groups. All of the lambs completed the protocol. Mean lecithin/sphingomyelin ratio increased significantly in amniotic (<em>p</em>=0.03) and alveolar fluid (<em>p</em>=0.03) samples of surfactant-treated animals. Lung function in terms of pressure–volume curves did not differ between two groups. Type II pneumocyte density tended to be higher (<em>p</em>=0.057) after intra-amniotic surfactant administration. Single-dose treatment with intra-amniotic surfactant seems to improve amniotic and alveolar lecithin/sphingomyelin ratio questionably by increasing alveolar type II cells. Pressure–volume relationships from inflation of the lungs might be unaltered with intra-amniotic surfactant treatment.</p></div>\",\"PeriodicalId\":77206,\"journal\":{\"name\":\"Journal of experimental animal science\",\"volume\":\"43 4\",\"pages\":\"Pages 301-307\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-02-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.jeas.2006.09.004\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of experimental animal science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0939860006000125\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of experimental animal science","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0939860006000125","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Evaluation of intra-amniotic surfactant administration for lung maturation in preterm sheep
We aimed to evaluate the effects of intra-amniotic surfactant administration on alveolar lecithin/sphingomyelin ratio, density of type II pneumocytes, and fetal lung function in preterm merino sheep. Pregnant ewes at 119 days gestation either received 200 mg intra-amniotic surfactant (n=4) or saline solution (n=4). After 24 h, the lambs were delivered by hysterotomy and mechanically ventilated. Lecithin/sphingomyelin ratios in alveolar fluid, inflating pressure–volume relationships, and type II pneumocyte counts in histological specimens were compared among the groups. All of the lambs completed the protocol. Mean lecithin/sphingomyelin ratio increased significantly in amniotic (p=0.03) and alveolar fluid (p=0.03) samples of surfactant-treated animals. Lung function in terms of pressure–volume curves did not differ between two groups. Type II pneumocyte density tended to be higher (p=0.057) after intra-amniotic surfactant administration. Single-dose treatment with intra-amniotic surfactant seems to improve amniotic and alveolar lecithin/sphingomyelin ratio questionably by increasing alveolar type II cells. Pressure–volume relationships from inflation of the lungs might be unaltered with intra-amniotic surfactant treatment.